Sierra Oncology, Inc. Debt to Equity Ratio 2015-2022 | SRRA
Current and historical debt to equity ratio values for Sierra Oncology, Inc. (SRRA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Sierra Oncology, Inc. debt/equity for the three months ending March 31, 2022 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2022-03-31 | $0.02B | $0.26B | 0.07 |
| 2021-12-31 | $0.01B | $0.10B | 0.14 |
| 2021-09-30 | $0.01B | $0.10B | 0.10 |
| 2021-06-30 | $0.01B | $0.08B | 0.12 |
| 2021-03-31 | $0.01B | $0.10B | 0.09 |
| 2020-12-31 | $0.01B | $0.10B | 0.10 |
| 2020-09-30 | $0.01B | $0.11B | 0.07 |
| 2020-06-30 | $0.01B | $0.12B | 0.08 |
| 2020-03-31 | $0.01B | $0.13B | 0.06 |
| 2019-12-31 | $0.07B | $0.09B | 0.75 |
| 2019-09-30 | $0.01B | $0.06B | 0.23 |
| 2019-06-30 | $0.01B | $0.07B | 0.19 |
| 2019-03-31 | $0.01B | $0.08B | 0.15 |
| 2018-12-31 | $0.02B | $0.09B | 0.16 |
| 2018-09-30 | $0.01B | $0.11B | 0.12 |
| 2018-06-30 | $0.01B | $0.12B | 0.07 |
| 2018-03-31 | $0.01B | $0.13B | 0.04 |
| 2017-12-31 | $0.01B | $0.10B | 0.08 |
| 2017-09-30 | $0.01B | $0.10B | 0.06 |
| 2017-06-30 | $0.01B | $0.11B | 0.05 |
| 2017-03-31 | $0.01B | $0.12B | 0.04 |
| 2016-12-31 | $0.01B | $0.10B | 0.08 |
| 2016-09-30 | $0.01B | $0.11B | 0.13 |
| 2016-06-30 | $0.01B | $0.13B | 0.06 |
| 2016-03-31 | $0.01B | $0.14B | 0.05 |
| 2015-12-31 | $0.01B | $0.15B | 0.05 |
| 2015-09-30 | $0.00B | $0.16B | 0.02 |
| 2015-06-30 | $0.31B | $-0.28B | -1.11 |
| 2015-03-31 | $0.16B | $-0.13B | -1.29 |
| 2014-12-31 | $0.15B | $-0.11B | -1.38 |
| 2014-09-30 | $0.00B | 0.00 | |
| 2014-06-30 | $0.00B | 0.00 | |
| 2014-03-31 | $0.00B | 0.00 | |
